StonvexLoading…
StonvexStonvexStonvexCore line items from BBAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $127.67M | $158.24M | $114.41M | $72.90M |
Operating Income | $-213.90M | $-133.42M | $-125.28M | $-114.74M |
Net Income | $-293.91M | $-295.55M | $-157.37M | $-142.23M |
EPS (Diluted) | $-0.82 | $-1.27 | $-0.69 | $-0.66 |
Total Assets | $894.55M | $343.78M | $354.08M | $360.88M |
Total Liabilities | $282.68M | $347.49M | $226.62M | $226.14M |
Cash & Equivalents | $87.13M | $50.14M | $65.58M | $72.27M |
Free Cash Flow OCF − CapEx | $-42.48M | $-38.60M | $-23.62M | $-21.58M |
Shares Outstanding | 436.96M | 251.55M | Not available | Not available |